Urinary excretions of albumin, glycosaminoglycans (GAGS), total sialic acid (TSA), and lipid associated sialic acid (LASA) were measured in 78 non-insulin dependent diabetic patients (NIDDM) and 28 healthy subjects. TSA excretion was significantly higher in normoalbuminuric and microalbuminuric diabetic subjects than the control subjects and TSA excretion was correlated with urinary albumin excretion rate (AER). In normoalbuminuric diabetics, the duration of diabetes correlated significantly with both sialicaciduria and albuminuria. Although serum TSA levels were significantly higher in both diabetic groups than the control subjects, there was no correlation between serum and urinary TSA levels.
ClampJRHartogMShelleyJH. Carbohydrate-containing materials in urine from normal and diabetic subjects. Clin Sci1979; 56: 193–6.
2.
BaggioBBrianiGCicerelloEGambaroGBruttomessoDTiengoAUrinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in nonalbuminuric diabetic patients. Nephron1986; 43: 187–90.
3.
MogensenCE. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria. Diabetes1990; 39: 761–7.
4.
VibertiGCHillRDJarrettRJArgyropoulosAMahmudUKeenH.Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet1982; i: 1430–2.
5.
CheungCKCockramCSYeungVTFSwaminathanR.Urinary excretion of transferrin by non- insulin-dependent diabetics: A marker for early complications?Clin Chem1989; 35: 1672–4.
6.
McCormickCPKonenJCShihabiZK. Microtransferrinuria and microalbuminuria. I. In the diabetic human. Clin Physiol Biochem1990; 8: 53–8.
7.
OzbenT.Elevated serum and sialic acid levels in renal diseases. Ann Clin Biochem1991; 28: 44–8.
8.
AsamiTTanakaAGunjiTSakaiK.Elevated serum and urine sialic acid levels in renal diseases of childhood. Clin Nephrol1985; 23: 112–9.
9.
BaggioBBrianiGCicerelloEGambaroGBorsattiACrepaldiG.Urinary glycosaminoglycan excretion and microalbuminuria in diabetes. J Am Med Assoc1986; 255: 3250–1.
10.
National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other catagories of glucose intolerance. Diabetes1979; 28: 1039.
11.
PennockCA. A modified screening test for glycosaminoglycan excretion. J Clin Path1969; 22: 379.
12.
PennockCA. A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of the mucopolysaccharidoses. J Clin Path1976; 29: 111–23.
13.
WatersPJLewryEPennockCA. Measurement of sialic acid in serum and urine: Clinical applications and limitations. Ann Clin Biochem1992; 29: 625–37.
14.
PlucinskiMCRileyWMProrokJ JAlhadeffJA. Total and lipid associated serum sialic acid levels in cancer patients with different primary sites and different degrees of metastatic involvement. Cancer1986; 58: 2680–5.
15.
KatopodisNHirshautYGellerNLStockCC. Lipid-associated sialic acid test for the detection of human cancer. Cancer Res1982; 42: 5270–5.
16.
KatopodisNStockCC. Improved method to determine lipid-bound sialic acid in plasma and serum. Res Commun Chem Path Pharmacol1980; 30: 171–80.
17.
BakerJRMetcalfPAJohnsonRNNewmanDRietzP.Use of protein based standards in automated colorimetric determinations of fructosamine in serum. Clin Chem1985; 31: 1550–4.
MathiesanERRonnBJensenTStormBDeckertT.Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria. Diabetes1990; 39: 245–9.
20.
ChanJCNYeungVTFCheungCKSwaminathanRCockramCS. The inter-relationship between albuminuria, plasma albumin concentration and indices of glycaemic control in non-insulin dependent diabetes mellitus. Clin Chim Acta1992; 210: 179–85.
21.
GavellaMLipovacVMrzljakV.Lipid-bound sialic acid in diabetes. Horm Metabol Res1989; 21: 280–1.
